Replies to post #35090 on Biotech Values

[DewDiligence]

Good catch, ‘go seek’. As you previously noted (#msg-13734346), data from the phase-2b trial in treatment-refractory patients are apparently being kept under warps and will not be reported at AASLD.

I will edit the calendar file accordingly.